Views & Analysis Finding your voice: big data’s big potential in scientific d... Examining the reach, quantity and quality of medical and pharma company outputs.
Views & Analysis A new age: the real-world development pathway Pharma must be prepared to work collaboratively to establish the best benefit-risk profiles and outcomes.
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
Views & Analysis From treatment to technology: a personal journey William King, founder and executive chairman of Zephyr Health, on using predictive insights for business transformation.
Views & Analysis Exclusive: Frontiers Health – Day two coverage Frontiers Health is a two-day event focused on disruptive health; innovative technology, application of digital and new ideas which can, are and will transform the face
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
